Table I3WHO assessment for Case Series and Case Reports Included for SCIT

StudyHow was the Adverse Event Classified?Was the Adverse Event Related to the Intervention?Causality
Cardona, 201453Dose related and time relatedYesProbably/likely
Copenhaver, 201149Dose related and time relatedYesProbably/likely
Dong, 201756Dose related and time relatedYesProbably/likely
Garde, 2005102Dose relatedNot reportedUnassessible/Unclassifiable
Kartal, 201548Not clearYesUnassessible/Unclassifiable
Lim,201757Dose related and time relatedYesProbably/likely
Kim, 201144Dose related and time relatedYesCertain
Ozden, 200946time relatedYesProbable/likely
Rank, 201442Dose relatedYesCertain
Sana, 201343Not dose relatedYesPossible
Sanchez-Morillas, 200545time relatedYesPossible
Santos, 201554Dose related and time relatedNot reportedProbably/likely

From: Appendix I., Risk of Bias Assessment

Cover of The Role of Immunotherapy in the Treatment of Asthma
The Role of Immunotherapy in the Treatment of Asthma [Internet].
AHRQ Comparative Effectiveness Reviews, No. 196.
Lin SY, Azar A, Suarez-Cuervo C, et al.
Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.